GHK-Cu Formulation Stability: EDTA, Vitamin C and Batch Checks

GHK-Cu formulation stability depends on the complete formula, processing conditions and the supplied raw-material batch. For a serum containing EDTA, vitamin C or other actives, review compatibility with the exact ingredients and concentrations before setting a shelf life. A high purity number alone cannot answer that question.

Start with Copper Tripeptide-1 identity and batch data

Copper Tripeptide-1, commonly called GHK-Cu, is listed as CAS 89030-95-5 in the PathGene product and batch documents. The company COA for batch PGGHK-260605 reports purity 99.55%, copper content 11.80% and GHK content 72.10% as separate results. Those values belong to that batch and its specification. They are not interchangeable percentages or a guarantee for every future lot.

Review the GHK-Cu powder specification and sample options and request the offered lot's COA before approving bulk material. Ask which method and reporting basis apply to each field; an elemental copper result alone does not establish the coordination state of the material.

What published stability research can establish

A preformulation study reported degradation under alkaline and oxidative stress, with different behavior in the tested water and buffer systems. These experiments support checking the formulation conditions; they do not establish a universal serum pH or a shelf life for a commercial formula. See Badenhorst et al., GHK-Cu preformulation study.

A separate study used several techniques to examine copper complex equilibria and found different species and stabilities under its experimental conditions. This illustrates why identity, copper content and coordination evidence should be reviewed separately. See Conato et al., copper complexes of GHK.

How to evaluate EDTA and vitamin C in a GHK-Cu formula

Treat EDTA, ascorbic acid, vitamin C derivatives and other actives as specific compatibility questions. Record the ingredient's exact chemical identity, concentration, formula pH, addition sequence and processing temperature. A result for one vitamin C form or one concentration does not establish compatibility for all derivatives. These cited studies do not provide a universal pass/fail threshold for EDTA or vitamin C in your formula.

For development screening, compare the intended formula with an appropriate control without the ingredient being evaluated, keeping other variables consistent. Track color, pH and appearance alongside an analytical method that can distinguish the target material from relevant degradation products. A color change is an observation to investigate; unchanged color alone is not proof of chemical stability.

Separate powder storage from finished-formula shelf life

The PGGHK-260605 COA specifies sealed packaging in a cool, dry place protected from light. Confirm storage and transport instructions for the actual offered lot. A powder COA or expiry date does not establish the storage life of a dissolved stock or finished serum. Evaluate the final formulation and its packaging under the intended conditions.

A practical checklist before a bulk order

• Match Copper Tripeptide-1 identity, batch number, specification and sample.
• Review purity, copper content and GHK content separately, with their methods and reporting bases.
• Define compatibility tests for the actual EDTA, vitamin C and other ingredients being used.
• Agree on stability criteria, packaging and storage conditions for the finished formula.
• Request the current batch COA and a sample through the GHK-Cu product page; confirm any additional characterization needed for the project.

For reviewing analytical documents, see the HPLC purity and assay guide and PathGene quality documentation.